FSHD Society is funding the expansion of the FSHD Clinical Trial Research Network

LEXINGTON, Mass. (PRWEB) August 11, 2020 The FSHD Society announced today that it has awarded $300,000 a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on funding of $300,000 a year in 2021 and 2022. The ne…

Source link

Related posts

<p>Please provide us with a list of your favorite antelopes I am BEGGING you</p>


Applications of Protein Engineering and Directed Evolution in Plant Research


Two Is Better than One: Dual SEC11 Binding Sites Regulate SYP121-Mediated Vesicle Trafficking


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World